The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.
about
Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Characterization of transcriptional modules related to fibrosing-NAFLD progression.Choline's role in maintaining liver function: new evidence for epigenetic mechanisms.Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.Micro RNAs in the development of non-alcoholic fatty liver disease.Characterisation of liver fat in the UK Biobank cohort.Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis.Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response.Murine models provide insight to the development of non-alcoholic fatty liver disease.Total body weight loss of ≥ 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis.Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis.In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells.Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemic.
P2860
Q30355082-D7282CE5-DD82-4DE4-9267-9BD42DCC54C8Q31171499-AF150430-2F65-4203-BEBE-4880903CCAD0Q33881352-4C0123FD-D163-4061-BAC1-C7BFA0E0498FQ34036012-876B31F5-F924-4512-8579-225DA31C3718Q34099690-944F22BB-B3A6-4E35-9ED8-301DE65A028EQ35127045-E5AAE656-6703-4C30-9FEB-35FB491B8474Q36291704-6EE274AF-7AAD-4F2B-ADFC-AA5F60259E7BQ36323714-85824FE1-AF68-4A0B-BFDC-8AFFEB821D11Q37249919-57A12E9D-1FD6-4D53-A873-6B90B008220BQ37696171-0EB7B54B-F89D-4992-813C-6E41F78049E0Q40505261-129DDCEA-BD1B-420B-B956-9CBEE48C7827Q42134707-BA64136D-9DB7-4978-AE46-07FF047E054FQ42186319-1C7D0E6E-E47D-4C1A-807A-5A6200956094Q42613401-CEF0DEB1-ED41-48D9-B75D-E9C1FB79ECA3Q43073218-890E6A41-6D56-439B-825E-911BEF5879F3Q53603517-06E33BFD-0603-41C2-9797-727C84DFB7D0Q55074201-19FBD240-0C1F-4F4B-990B-EA5AB70F77D6
P2860
The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@ast
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@en
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@nl
type
label
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@ast
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@en
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@nl
prefLabel
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@ast
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@en
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@nl
P2860
P1476
The relevance of liver histolo ...... nonalcoholic steatohepatitis.
@en
P2093
Arthur J McCullough
Mangesh R Pagadala
P2860
P304
P356
10.1016/J.CLD.2012.05.006
P577
2012-06-27T00:00:00Z